Raia Drogasil S.A.
RADL3
Clasificación en acciones
#2618
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal... Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Precio por acción
$4.16
Capitalización bursátil
$7.28B
Cambio (1 día)
1.45%
Cambio (1 año)
14.93%
País
BR
Comercio Raia Drogasil S.A. (RADL3)
Categoría
Consumer Defensive
Ganancias de Raia Drogasil S.A. (RADL3)
Ganancias en Jun 2026 TTM: $288.64M
Secondo gli ultimi rapporti finanziari di Raia Drogasil S.A., gli utili attuali della società sono $288.64M. Nel 2023, la società ha registrato un utile di $250.74M, un aumento con respecto a agli utili del 2022, che erano di $225.70M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Raia Drogasil S.A. desde 2003 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $288.64M | 25.99% |
| 2024 | $229.10M | -8.63% |
| 2023 | $250.74M | 11.09% |
| 2022 | $225.70M | 27.37% |
| 2021 | $177.20M | 49.32% |
| 2020 | $118.68M | -39.16% |
| 2019 | $195.07M | 18.52% |
| 2018 | $164.59M | -20.60% |
| 2017 | $207.30M | 13.31% |
| 2016 | $182.95M | 65.89% |
| 2015 | $110.28M | -2.84% |
| 2014 | $113.50M | 92.24% |
| 2013 | $59.04M | -23.49% |
| 2012 | $77.16M | 57.81% |
| 2011 | $48.90M | -32.82% |
| 2010 | $72.78M | 20.53% |
| 2009 | $60.39M | 100.99% |
| 2008 | $30.05M | 71.58% |
| 2007 | $17.51M | 33.62% |
| 2006 | $13.10M | 131.37% |
| 2005 | $5.66M | 42.39% |
| 2004 | $3.98M | 20.41% |
| 2003 | $3.30M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $20.38B | 6,959.56% |
US
|
|
| $9.83B | 3,304.31% |
FR
|
|
| $2.94B | 918.90% |
US
|
|
| $1.55B | 436.99% |
IN
|
|
| $517.00M | 79.11% |
US
|
